View the full 2023 Interactive PANRE/PANRE-LA Blueprint or download it in MSWord Format. Additional versions of all blueprints and study plans are accessible here.
Click here to access the PANRE-LA Smart Search
| 2023 PANRE/PANRE-LA Dermatologic System Blueprint – 5% | ||||
| Smarty PANCE is not sponsored or endorsed by, or affiliated with, the National Commission on Certification of Physician Assistants. Information on the performance expectations along with the official NCCPA PANRE and PANRE-LA Content Blueprint is accessible on the NCCPA website. | ||||
| Performance Expectation | ||||
| History & Physical | Diagnosis | Intervention (Basic) | Intervention (Complex) | |
| Acne vulgaris | · | · | · | |
| Actinic keratosis | · | · | · | |
| Alopecia | · | · | ||
| Atopic dermatitis | · | · | · | |
| Basal cell carcinoma | · | · | ||
| Bites (animal, insect, human) | · | · | · | |
| Burns | · | · | · | |
| Cold injuries | · | · | ||
| Contact dermatitis | · | · | · | |
| Dermatophyte infections | · | · | · | |
| Drug eruptions | · | · | · | |
| Erythema multiforme | · | · | ||
| Hidradenitis suppurativa | · | · | · | |
| Lipomas | · | · | ||
| Localized skin infections (cellulitis, erysipelas, abscesses, impetigo, carbuncles, furuncles) | · | · | · | · |
| Melanoma | · | · | · | |
| Molluscum contagiosum | · | · | · | |
| Necrotizing soft-tissue infection | · | · | · | |
| Onychomycosis | · | · | · | |
| Paronychia | · | · | · | |
| Pigmentation disorders (vitiligo, acanthosis, melasma) | · | · | ||
| Pilonidal disease | · | · | · | |
| Pityriasis rosea | · | · | ||
| Psoriasis | · | · | · | |
| Rosacea | · | · | · | |
| Roseola | · | · | ||
| Seborrheic dermatitis | · | · | · | |
| Severe cutaneous adverse reactions (toxic epidermal necrolysis, Stevens-Johnson syndrome, staphylococcal scalded skin syndrome) | · | · | ||
| Skin infestations (scabies, lice) | · | · | · | |
| Squamous cell carcinoma | · | · | ||
| Ulcers (pressure, diabetic) | · | · | · | |
| Urticaria | · | · | · | |
| Dermatology Exam | Take Exam | |||
| 2022 PANRE Dermatologic System Blueprint: 6% | |||
| Smarty PANCE is not sponsored or endorsed by, or affiliated with, the National Commission on Certification of Physician Assistants | |||
| Diseases and Disorders | Level 1 | Level 2 | Level 3 |
| Acne vulgaris | • | • | |
| Actinic keratosis | • | • | |
| Acute urticaria, Drug eruptions | • | • | |
| Atopic dermatitis | • | • | |
| Basal cell carcinoma | • | ||
| Burns | • | • | |
| Cellulitis, Erysipelas | • | • | • |
| Contact dermatitis | • | • | |
| Erythema multiforme | • | ||
| Herpes simplex virus | • | • | |
| Hidradenitis suppurativa | • | • | |
| Impetigo | • | • | |
| Lipomas/epidermal inclusion cysts | • | • | |
| Melanoma | • | ||
| Molluscum contagiosum | • | • | |
| Onychomycosis, Dermatophyte infections | • | • | |
| Paronychia | • | • | |
| Pilonidal disease | • | • | |
| Pityriasis rosea | • | • | |
| Pressure ulcers | • | • | |
| Psoriasis | • | • | |
| Rosacea | • | • | |
| Scabies, Lice infestation | • | • | |
| Seborrheic dermatitis | • | • | |
| Spider bites | • | • | |
| Squamous cell carcinoma | • | ||
| Toxic epidermal necrolysis, Stevens-Johnson syndrome | • | ||
| Dermatology Exam | Take Exam | ||
- Level 1: Recognize most likely diagnosis using signs, symptoms, and risks; refer appropriately.
- Level 2: Make appropriate diagnosis by recognizing signs, symptoms, risks, and/or interpreting results of diagnostic studies, and have knowledge of first-line treatment.
- Level 3: Make appropriate diagnosis by recognizing signs, symptoms, risks, and/or interpreting results of diagnostic studies and have knowledge of first-line treatment. In addition, have the knowledge required to manage well-known comorbid conditions, contraindications, and complications.
